{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:16:55Z","timestamp":1788419815335,"version":"build-2803163510"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) has been continuously increasing. However, the pathogenesis of MASLD is quite complex and involves multiple factors, leading to a lack of targeted therapeutic drugs for MASLD. Ling-Gui-Zhu-Gan Decoction (LGZGD) has demonstrated significant hepatoprotective and lipid-lowering effects, yet its mechanism of action against MASLD remains incompletely understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we established a high-fat diet-induced MASLD rat model to investigate the pharmacological effects of LGZGD on MASLD from the perspectives of gut microbiota and lipidomics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Using UPLC-Q-TOF-MS analysis, we putatively identified 83 chemical components in LGZGD, primarily flavones and terpenoids, which may represent the key active constituents responsible for its ameliorative effects. In MASLD model rats, LGZGD treatment reduced the levels of TC, TG, AST, ALT, and LDL-C in both serum and liver tissue, while increasing HDL-C levels. Analysis of the gut microbiota revealed that LGZGD treatment increased the abundance of\n                      <jats:italic>g__Collinsella<\/jats:italic>\n                      and\n                      <jats:italic>g__Prevotellaceae_UCG-003<\/jats:italic>\n                      , and decreased the abundance of\n                      <jats:italic>g__Faecalibaculum<\/jats:italic>\n                      . Furthermore, LGZGD was found to regulate 831 lipids, primarily involved in metabolic pathways such as glycerophospholipid, glycerolipid, and sphingolipid metabolism.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrates that LGZGD prevents MASLD, and its mechanism of action involves the regulation of gut microbiota and the modulation of lipid metabolism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmicb.2026.1916850","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:54:08Z","timestamp":1788418448000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Unraveling the ameliorative effects of Ling-Gui-Zhu-Gan decoction on MASLD: an integrative gut microbiota and lipidomic study"],"prefix":"10.3389","volume":"17","author":[{"given":"Juanhong","family":"Lei","sequence":"first","affiliation":[{"name":"The First Clinical College, Yunnan University of Chinese Medicine","place":["Kunming, China"]},{"name":"School of Chinese Materia Medica and Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan University of Chinese Medicine","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dihong","family":"Gong","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica and Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan University of Chinese Medicine","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica and Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan University of Chinese Medicine","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"The First Clinical College, Yunnan University of Chinese Medicine","place":["Kunming, China"]},{"name":"School of Chinese Materia Medica and Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan University of Chinese Medicine","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[{"name":"The First Clinical College, Yunnan University of Chinese Medicine","place":["Kunming, China"]},{"name":"School of Chinese Materia Medica and Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan University of Chinese Medicine","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanrong","family":"Qiao","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica and Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan University of Chinese Medicine","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxin","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica and Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan University of Chinese Medicine","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica and Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan University of Chinese Medicine","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"107618","DOI":"10.1016\/j.pharmthera.2020.107618","article-title":"Glycyrrhizin: an alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?","volume":"214","author":"Bailly","year":"2020","journal-title":"Pharmacol. Ther"},{"key":"B2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13020-021-00559-3","article-title":"Traditional Chinese medicine Lingguizhugan decoction ameliorate HFD-induced hepatic-lipid deposition in mice by inhibiting STING-mediated inflammation in macrophages","volume":"17","author":"Cao","year":"2022","journal-title":"Chin. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12906-018-2424-1","article-title":"The traditional Chinese formulae Ling-Gui-Zhu-Gan decoction alleviated non-alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules","volume":"19","author":"Dang","year":"2019","journal-title":"BMC Complement. Altern. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"959495","DOI":"10.3389\/fimmu.2022.959495","article-title":"Glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease","volume":"13","author":"Fan","year":"2022","journal-title":"Front. Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"969524","DOI":"10.3389\/fmicb.2022.969524","article-title":"Alterations in gut microbiota improve SCFA production and fiber utilization in Tibetan pigs fed alfalfa diet","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/09168451.2018.1559025","article-title":"review of the studies on food-derived factors which regulate energy metabolism via the modulation of lipid-sensing nuclear receptors","volume":"83","author":"Goto","year":"2019","journal-title":"Biosci. Biotechnol. Biochem"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1007274","DOI":"10.3389\/fphar.2022.1007274","article-title":"Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR\/PPAR\u03b1-SREBPs pathway","volume":"13","author":"He","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plipres.2014.06.002","article-title":"Phosphatidylserine in the brain: metabolism and function","volume":"56","author":"Kim","year":"2014","journal-title":"Prog. Lipid Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.dsx.2020.09.026","article-title":"Pathophysiological mechanisms underlying MAFLD","volume":"14","author":"Kuchay","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.phrs.2019.04.025","article-title":"Natural products in licorice for the therapy of liver diseases: progress and future opportunities","volume":"144","author":"Li","year":"2019","journal-title":"Pharmacol. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"155285","DOI":"10.1016\/j.phymed.2023.155285","article-title":"Formononetin promotes fatty acid \u03b2-oxidation to treat non-alcoholic steatohepatitis through SIRT1\/PGC-1\u03b1\/PPAR\u03b1 pathway","volume":"124","author":"Liao","year":"2024","journal-title":"Phytomedicine"},{"key":"B12","author":"Liu","year":"2017","journal-title":"Atractylenolide I attenuates TNF-"},{"key":"B13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.12998\/wjcc.v6.i10.355","article-title":"PNPLA3 rs139051 is associated with phospholipid metabolite profile and hepatic inflammation in nonalcoholic fatty liver disease","volume":"6","author":"Luo","year":"2018","journal-title":"World J. Clin. Cases"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/cbin.10323","article-title":"Abnormal differentiation of intestinal epithelium and intestinal barrier dysfunction in diabetic mice associated with depressed Notch\/NICD transduction in Notch\/Hes1 signal pathway","volume":"38","author":"Min","year":"2014","journal-title":"Cell Biol. Int"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.2147\/DMSO.S370492","article-title":"Lingguizhugan decoction targets intestinal microbiota and metabolites to reduce insulin resistance in high-fat diet rats","volume":"15","author":"Ning","year":"2022","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"B16","doi-asserted-by":"publisher","first-page":"6020","DOI":"10.1038\/s41467-022-33735-6","article-title":"TLCD1 and TLCD2 regulate cellular phosphatidylethanolamine composition and promote the progression of non-alcoholic steatohepatitis","volume":"13","author":"Petkevicius","year":"2022","journal-title":"Nat. Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"116178","DOI":"10.1016\/j.foodres.2025.116178","article-title":"Multi-omics joint analysis: pachymic acid ameliorated non-alcoholic fatty liver disease by regulating gut microbiota","volume":"209","author":"Ren","year":"2025","journal-title":"Food Res. Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12072-025-10953-w","article-title":"Small extracellular vesicles derived from lipotoxic hepatocytes transport FASN to promote hepatic stellate cell activation","volume":"20","author":"Shi","year":"2026","journal-title":"Hepatol. Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1111\/1541-4337.12603","article-title":"Mass spectrometry-based lipidomics in food science and nutritional health: a comprehensive review","volume":"19","author":"Sun","year":"2020","journal-title":"Compr. Rev. Food Sci. Food Saf"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1426049","DOI":"10.3389\/fphar.2024.1426049","article-title":"Lingguizhugan oral solution alleviates MASLD by regulating bile acids metabolism and the gut microbiota through activating FXR\/TGR5 signaling pathways","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"37275","DOI":"10.31083\/IJVNR37275","article-title":"Vitamin K2 alleviates metabolic dysfunction-associated steatotic liver disease through mitochondrial dysfunction modulation via gut microbiota","volume":"95","author":"Wang","year":"2025","journal-title":"Int. J. Vitam. Nutr. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.hbpd.2021.05.008","article-title":"LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver","volume":"20","author":"Wang","year":"2021","journal-title":"HBPD Int"},{"key":"B23","author":"Wei","year":"2023","journal-title":"Effect of the Glycyrrhiza glabra L. extract to alleviate lipid accumulation in nonalcoholic fatty liver disease"},{"key":"B24","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3389\/fphys.2019.00918","article-title":"Linggui Zhugan Formula improves glucose and lipid levels and alters gut microbiota in high-fat diet-induced diabetic mice","volume":"10","author":"Wu","year":"2019","journal-title":"Front. Physiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"120893","DOI":"10.1016\/j.jep.2025.120893","article-title":"Ling-Gui-Zhu-Gan decoction improves hepatic steatosis through ALKBH1-mediated DNA N6-methyladenosine modification","volume":"357","author":"Xu","year":"2026","journal-title":"J. Ethnopharmacol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.3969\/j.issn.1672-5069.2020.03.039","article-title":"Brief introduction of an international expert consensus statement: a new definition of metabolic associated fatty liver disease","volume":"36","author":"Xue","year":"2020","journal-title":"J. Clin. Hepatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2790864","DOI":"10.1155\/2017\/2790864","article-title":"Lingguizhugan decoction protects against high-fat-diet-induced nonalcoholic fatty liver disease by alleviating oxidative stress and activating cholesterol secretion","volume":"2017","author":"Yang","year":"2017","journal-title":"Int. J. Genomics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.syapm.2012.12.009","article-title":"Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula","volume":"36","author":"Yin","year":"2013","journal-title":"Syst. Appl. Microbiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11655-025-3845-6","article-title":"Sanren decoction ameliorates metabolic dysfunction-associated steatotic liver disease by protecting mitochondrial function","volume":"32","author":"Yin","year":"2026","journal-title":"Chin. J. Integr. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/ptr.6598","article-title":"Protective effects of glycycoumarin on liver diseases","volume":"34","author":"Zhang","year":"2020","journal-title":"Phytother. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1589871","DOI":"10.1155\/2017\/1589871","article-title":"Erchen decoction and linguizhugan decoction ameliorate hepatic insulin resistance by inhibiting IRS-1Ser307 phosphorylation in vivo and in vitro","volume":"2017","author":"Zhang","year":"2017","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"B32","volume-title":"Synopsis of Prescriptions of the Golden Chamber","author":"Zhang","year":"1994"},{"key":"B33","doi-asserted-by":"publisher","first-page":"115459","DOI":"10.1016\/j.jep.2022.115459","article-title":"Betulinic acid prevents liver fibrosis by binding Lck and suppressing Lck in HSC activation and proliferation","volume":"296","author":"Zhao","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"82621","DOI":"10.18632\/oncotarget.19734","article-title":"Lingguizhugan decoction improves non-alcoholic fatty liver disease by altering insulin resistance and lipid metabolism related genes: a whole trancriptome study by RNA-Seq","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1916850\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:54:10Z","timestamp":1788418450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1916850\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":34,"alternative-id":["10.3389\/fmicb.2026.1916850"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1916850","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1916850"}}